[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Polypeptide Drug Market Report 2018

January 2018 | 113 pages | ID: U5D5C928274EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Polypeptide Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Polypeptide Drug in these regions, from 2013 to 2025 (forecast).
United States Polypeptide Drug market competition by top manufacturers/players, with Polypeptide Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis
  • Merck Serono
  • Ferring Pharmaceuticals
  • Ipsen PHarma Biotech
  • Lilly
  • Asahi Kasei
  • AstraZeneca
  • SciClone Pharmaceuticals
  • Takeda
  • Roche
  • Sanofi
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Injection
  • Nasal administration
  • Lung administration
  • Oral administration
  • Transdermal administration
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Immunity Regulating Medicine (Allergy Infection and Immune)
  • Digestive System Drugs (Gastrointestinal Type)
  • Bone and Connective Tissue Types (Thyroid hormones Drug)
  • Gynecologic or Obstetric Drug
  • Tumor Drug
  • Urinary System Drug
  • Metabolic Drug (Insulin and Other Hypoglycemic Agents)
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Polypeptide Drug Market Report 2018

1 POLYPEPTIDE DRUG OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug by Product Category
  1.2.1 United States Polypeptide Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Polypeptide Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Injection
  1.2.4 Nasal administration
  1.2.5 Lung administration
  1.2.6 Oral administration
  1.2.7 Transdermal administration
1.3 United States Polypeptide Drug Market by Application/End Users
  1.3.1 United States Polypeptide Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
  1.3.3 Digestive System Drugs (Gastrointestinal Type)
  1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
  1.3.5 Gynecologic or Obstetric Drug
  1.3.6 Tumor Drug
  1.3.7 Urinary System Drug
  1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 United States Polypeptide Drug Market by Region
  1.4.1 United States Polypeptide Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Polypeptide Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Polypeptide Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Polypeptide Drug Status and Prospect (2013-2025)
  1.4.5 New England Polypeptide Drug Status and Prospect (2013-2025)
  1.4.6 The South Polypeptide Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Polypeptide Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Polypeptide Drug (2013-2025)
  1.5.1 United States Polypeptide Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Polypeptide Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES POLYPEPTIDE DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Polypeptide Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Polypeptide Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Polypeptide Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Polypeptide Drug Market Competitive Situation and Trends
  2.4.1 United States Polypeptide Drug Market Concentration Rate
  2.4.2 United States Polypeptide Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Polypeptide Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Polypeptide Drug Sales and Market Share by Region (2013-2018)
3.2 United States Polypeptide Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Polypeptide Drug Price by Region (2013-2018)

4 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Polypeptide Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Polypeptide Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Polypeptide Drug Price by Type (2013-2018)
4.4 United States Polypeptide Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES POLYPEPTIDE DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Polypeptide Drug Sales and Market Share by Application (2013-2018)
5.2 United States Polypeptide Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES POLYPEPTIDE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Polypeptide Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck Serono
  6.2.2 Polypeptide Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Ferring Pharmaceuticals
  6.3.2 Polypeptide Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Ipsen PHarma Biotech
  6.4.2 Polypeptide Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Lilly
  6.5.2 Polypeptide Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Asahi Kasei
  6.6.2 Polypeptide Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Polypeptide Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 SciClone Pharmaceuticals
  6.8.2 Polypeptide Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Takeda
  6.9.2 Polypeptide Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Roche
  6.10.2 Polypeptide Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Roche Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Sanofi

7 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

7.1 Polypeptide Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polypeptide Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polypeptide Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES POLYPEPTIDE DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Polypeptide Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Polypeptide Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Polypeptide Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Polypeptide Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Polypeptide Drug
Figure United States Polypeptide Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Polypeptide Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Nasal administration Product Picture
Figure Lung administration Product Picture
Figure Oral administration Product Picture
Figure Transdermal administration Product Picture
Figure United States Polypeptide Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Polypeptide Drug by Application in 2017
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Examples
Table Key Downstream Customer in Immunity Regulating Medicine (Allergy Infection and Immune)
Figure Digestive System Drugs (Gastrointestinal Type) Examples
Table Key Downstream Customer in Digestive System Drugs (Gastrointestinal Type)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Examples
Table Key Downstream Customer in Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure Gynecologic or Obstetric Drug Examples
Table Key Downstream Customer in Gynecologic or Obstetric Drug
Figure Tumor Drug Examples
Table Key Downstream Customer in Tumor Drug
Figure Urinary System Drug Examples
Table Key Downstream Customer in Urinary System Drug
Figure Metabolic Drug (Insulin and Other Hypoglycemic Agents) Examples
Table Key Downstream Customer in Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure United States Polypeptide Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Polypeptide Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Polypeptide Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Polypeptide Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Polypeptide Drug Sales Share by Players/Suppliers
Figure 2017 United States Polypeptide Drug Sales Share by Players/Suppliers
Figure United States Polypeptide Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Polypeptide Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Polypeptide Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Polypeptide Drug Revenue Share by Players/Suppliers
Figure 2017 United States Polypeptide Drug Revenue Share by Players/Suppliers
Table United States Market Polypeptide Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Polypeptide Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Polypeptide Drug Market Share of Top 3 Players/Suppliers
Figure United States Polypeptide Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Polypeptide Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Polypeptide Drug Product Category
Table United States Polypeptide Drug Sales (K Pcs) by Region (2013-2018)
Table United States Polypeptide Drug Sales Share by Region (2013-2018)
Figure United States Polypeptide Drug Sales Share by Region (2013-2018)
Figure United States Polypeptide Drug Sales Market Share by Region in 2017
Table United States Polypeptide Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Polypeptide Drug Revenue Share by Region (2013-2018)
Figure United States Polypeptide Drug Revenue Market Share by Region (2013-2018)
Figure United States Polypeptide Drug Revenue Market Share by Region in 2017
Table United States Polypeptide Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Polypeptide Drug Sales (K Pcs) by Type (2013-2018)
Table United States Polypeptide Drug Sales Share by Type (2013-2018)
Figure United States Polypeptide Drug Sales Share by Type (2013-2018)
Figure United States Polypeptide Drug Sales Market Share by Type in 2017
Table United States Polypeptide Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Polypeptide Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Type (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Type in 2017
Table United States Polypeptide Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Polypeptide Drug Sales Growth Rate by Type (2013-2018)
Table United States Polypeptide Drug Sales (K Pcs) by Application (2013-2018)
Table United States Polypeptide Drug Sales Market Share by Application (2013-2018)
Figure United States Polypeptide Drug Sales Market Share by Application (2013-2018)
Figure United States Polypeptide Drug Sales Market Share by Application in 2017
Table United States Polypeptide Drug Sales Growth Rate by Application (2013-2018)
Figure United States Polypeptide Drug Sales Growth Rate by Application (2013-2018)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Novartis Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Novartis Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Serono Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Merck Serono Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Merck Serono Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Lilly Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Lilly Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Lilly Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Asahi Kasei Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales Growth Rate (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Takeda Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Takeda Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Takeda Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche Polypeptide Drug Sales Growth Rate (2013-2018)
Figure Roche Polypeptide Drug Sales Market Share in United States (2013-2018)
Figure Roche Polypeptide Drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Players/Suppliers in 2017
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure United States Polypeptide Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Polypeptide Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Polypeptide Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Polypeptide Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Polypeptide Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Polypeptide Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Polypeptide Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories